Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2099474

Cl.NCCCC[C@H](N)C(=O)OC(=O)[C@@H](N)CCCCN

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
DPP4 known ✓ P27487 2/20 0.41
GSR P00390 1/20 0.59
GNAI3 P08754 1/20 0.42
GNAO1 P09471 1/20 0.42
GNAI1 P63096 1/20 0.42
RNPEP Q9H4A4 1/20 0.42
DPP7 Q9UHL4 8/20 0.41
DPP8 Q6V1X1 4/20 0.41
DPP9 Q86TI2 4/20 0.41
CPB2 Q96IY4 3/20 0.41
ARG2 P78540 1/20 0.38
BLM P54132 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TLR2 O60603 1/20 0.38
FAP Q12884 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3825519 1.00 GSR (0.59) GSRGNAI3GNAO1GNAI1RNPEP
Hydrochloric Acid SCHEMBL11287494 0.98 GSR (0.57) GSRGNAI3GNAO1GNAI1RNPEP
Hydrochloric Acid SCHEMBL11287492 0.98 GSR (0.57) GSRGNAI3GNAO1GNAI1RNPEP
SCHEMBL344574 0.98 GSR (0.61) GSRGNAI3GNAO1GNAI1RNPEP
SCHEMBL20240364 0.98 GSR (0.61) GSRGNAI3GNAO1GNAI1RNPEP
SCHEMBL1404247 0.98 GSR (0.61) GSRGNAI3GNAO1GNAI1RNPEP
SCHEMBL680614 0.96 GSR (0.59) GSRGNAI3GNAO1GNAI1RNPEP
Lysine SCHEMBL28806096 0.92 GSR (0.74) GSRRNPEPCPB2ARG2BLM
SCHEMBL16194521 0.91 GSR (0.59) GSRGNAI3GNAO1GNAI1RNPEP
SCHEMBL997560 0.91 GSR (0.52) GSRGNAI3GNAO1GNAI1RNPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-57045145-A None JP disclosed
CN-112679371-B Preparation method of L-lysine hydrochloride beta crystal form 北京民康百草医药科技有限公司 2022-11-18 CN disclosed
CN-112679371-A Preparation method of L-lysine hydrochloride beta crystal form 北京民康百草医药科技有限公司 2021-04-20 CN disclosed
EP-2096176-B1 METHOD OF OBTAINING CRYSTAL OF HYDROCHLORIDE OF BASIC AMINO ACID AJINOMOTO KK (JP) 2017-04-12 EP disclosed
US-8372606-B2 Methods for obtaining crystals of a basic amino acid hydrochloride AJINOMOTO CO., INC. (JP) 2013-02-12 US disclosed
CN-101558164-B Method for obtaining crystals of hydrochloride of basic amino acid AJINOMOTO KK 2012-05-09 CN disclosed
US-8163865-B2 Biocompatible amino acid anhydride polymers UNIVERSITY OF WASHINGTON (US) 2012-04-24 US disclosed
US-20100015205-A1 BIOCOMPATIBLE AMINO ACID ANHYDRIDE POLYMERS WASHINGTON, UNIVERSITY OF (US) 2010-01-21 US disclosed
US-20090291477-A1 METHODS FOR OBTAINING CRYSTALS OF A BASIC AMINO ACID HYDROCHLORIDE AJINOMOTO CO., INC. (JP) 2009-11-26 US disclosed
CN-101558164-A Method of obtaining crystal of hydrochloride of basic amino acid AJINOMOTO KK (JP) 2009-10-14 CN disclosed
EP-2096176-A1 METHOD OF OBTAINING CRYSTAL OF HYDROCHLORIDE OF BASIC AMINO ACID Ajinomoto Co., Inc. (JP) 2009-09-02 EP disclosed
WO-2008098220-A1 BIOCOMPATILE AMINO ACID ANHYDRIDE POLYMERS UNIVERSITY OF WASHINGTON (US) 2008-08-14 WO disclosed
EP-1035109-B1 Aqueous lysine solution AJINOMOTO KK (JP) 2005-05-11 EP disclosed
US-20040214895-A1 Aqueous stable lysine solution AJINOMOTO CO., INC. (JP) 2004-10-28 US disclosed
US-20020123648-A1 Aqueous stable lysine solution AJINOMOTO CO., INC. (JP) 2002-09-05 US disclosed
US-6329548-B1 FEED ADDITIVE FOR PRODUCING A FEED FOR DOMESTIC ANIMALS SUCH AS CATTLE, PIGS AND CHICKENS AJINOMOTO CO., INC. (JP) 2001-12-11 US disclosed
US-20010043942-A1 Aqueous stable lysine solution AJINOMOTO, CO., INC. (JP) 2001-11-22 US disclosed
EP-1035109-A1 Aqueous lysine solution Ajinomoto Co., Inc. (JP) 2000-09-13 EP disclosed
JP-S5745145-A PREPARATION OF PACKAGED LYSINE HYCROCHLORIDE AJINOMOTO CO INC 1982-03-13 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100015205-A1 BIOCOMPATIBLE AMINO ACID ANHYDRIDE POLYMERS CRYAA, FIBP, LNPEP DPP4 1549/4885GSR 3746/4885GNAI3 2885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.